Nice thought but no, it won't. On the other hand to be successful it just needs to be as good as or slightly better than competitors in both performance and ease of deployment.
- Forums
- ASX - By Stock
- AVR
- Ann: DurAVR First in Human Study 12 Month Results
AVR
anteris technologies global corp.
Add to My Watchlist
0.49%
!
$6.12

Ann: DurAVR First in Human Study 12 Month Results, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.12 |
Change
-0.030(0.49%) |
Mkt cap ! $94.85M |
Open | High | Low | Value | Volume |
$6.21 | $6.21 | $6.00 | $16.53K | 2.704K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $6.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 240 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 6.010 |
2 | 1624 | 6.000 |
1 | 25 | 5.850 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 500 | 2 |
6.180 | 50 | 1 |
6.190 | 1000 | 1 |
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
Last trade - 15.46pm 25/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online